Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Fibrinogen-like 1 is a member of the fibrinogen family. Zusätzlich bieten wir Ihnen FGL1 Kits (34) und FGL1 Proteine (15) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 108 products:
Human Polyclonal FGL1 Primary Antibody für ELISA, WB - ABIN4316946
Liu, Ukomadu: Fibrinogen-like protein 1, a hepatocyte derived protein is an acute phase reactant. in Biochemical and biophysical research communications 2007
findings highlight the crucial role of HFREP1 in insulin (zeige INS Antikörper) resistance and diabetes, and provide a potential strategy and biomarker for developing therapeutic approaches to combat these diseases.
Hepassocin plays an important role in non-alcoholic fatty liver disease and induces hepatic lipid accumulation through an ERK1/2 (zeige MAPK1/3 Antikörper)-dependent pathway.
Here, the application of small ubiquitin-related modifier (SUMO) fusion technology in combination with four different chaperone teams on the soluble expression of recombinant HPS protein was explored and analyzed.
Findings suggest that hepassocin promotes hepatic cell line L02 cells proliferation via an autocrine mechanism and inhibits HCC (zeige FAM126A Antikörper) cells proliferation by an intracrine pathway.
data demonstrated that liver-specific gene LFIRE-1/HFREP-1 was frequently downregulated and might possess growth suppressor activity in HCC (zeige FAM126A Antikörper)
HFREP-1 in plasma almost completely bound to the fibrin matrix during clot (zeige TXNDC17 Antikörper) formation
The enhancement of FGL1 levels in vitro by IL-6 (zeige IL6 Antikörper) and its induction after turpentine oil injection suggest that it is an acute phase reactant.
HNF1 (zeige HNF1A Antikörper) binding site and HNF1alpha (zeige HNF1A Antikörper) are critical to liver-specific expression of HPS (zeige HPS1 Antikörper), and down-regulation or loss of HNF1alpha (zeige HNF1A Antikörper) causes, at least in part, the transcriptional down-regulation of HPS (zeige HPS1 Antikörper) in HCC (zeige FAM126A Antikörper).
The results suggest that Fgl1 acts as a tumor suppressor in hepatocellular cancer through an Akt (zeige AKT1 Antikörper)-dependent mechanism and support its role as a potential therapeutic target in hepatocellular carcinoma.
Fgl1 is a member of an emerging group of proteins with key roles in metabolism and liver regeneration.
HNF1 (zeige HNF1A Antikörper) binding site and HNF1alpha (zeige HNF1A Antikörper) are critical to liver-specific expression of HPS, and down-regulation or loss of HNF1alpha (zeige HNF1A Antikörper) causes, at least in part, the transcriptional down-regulation of HPS in HCC (zeige FAM126A Antikörper).
Fibrinogen-like 1 is a member of the fibrinogen family. This protein is homologous to the carboxy terminus of the fibrinogen beta- and gamma- subunits which contains the four conserved cysteines of fibrinogens and fibrinogen related proteins. However, this protein lacks the platelet-binding site, cross-linking region and a thrombin-sensitive site which are necessary for fibrin clot formation. This protein may play a role in the development of hepatocellular carcinomas. Four alternatively spliced transcript variants encoding the same protein exist for this gene.
, fibrinogen-like protein 1
, fibrinogen-related protein 1
, fibronigen-like protein 1
, liver fibrinogen-related protein 1
, hepatocellular carcinoma-related sequence
, hepatocyte-derived fibrinogen-related protein 1